ETFs
A
APVO
Aptevo Therapeutics Inc
4.615
-0.145-3.05%Opening11:12 06/10 EDT
OPEN/PREV CLOSE4.740/4.720
TODAY RANGE4.590-4.860
VOL15.81K
MARKET CAP6.06M
52 WEEK RANGE3.800-235.98
AVG VOL (3M)39.86K
% TURNOVER1.27%
TURNOVER--
P/E (TTM)-0.0238
% RANGE5.72%
EPS(TTM)-204.0503
P/E(FORWARD)-0.2014
P/B0.5038
BVPS9.65
DIVIDEND--
P/S3.509
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.05M
SHARES OUTSTANDING1.25M
NEXT EARNINGS08/10-08/14
FREE FLOAT1.25M
LOT SIZE1
EX-DATE12/30/2025
News
Press Releases
Financial Reports
Profile
PUBT·05/29 00:03
Aptevo Therapeutics files Form 3 for SVP, CSO Mary Jo Janatpour
TipRanks·05/28 12:44
Aptevo Therapeutics appoints Janatpour as SVP, CSO
TipRanks·05/27 20:52
Aptevo Forms Strategic Radiopharmaceutical Collaboration with Niowave
TipRanks·05/27 14:16
Aptevo, Niowave launch collab for radiopharmaceutical oncology programs
TipRanks·05/13 16:25
Aptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
Seeking Alpha·05/13 13:35
Aptevo Therapeutics reports Q1 results
TipRanks·05/07 06:10
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
TipRanks·05/06 20:52
Aptevo Highlights Strong Phase 1b AML Trial Results
Same Industry
Name/Symbol
Change%
Price